Complement in antineutrophil cytoplasmic antibody-associated vasculitis.

Area of Science:

• Immunology
• Nephrology
• Autoimmunity

Background:

• Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a group of autoimmune diseases.
• Previously, the complement system was thought to be uninvolved due to the "pauci-immune" renal histology.
• Emerging evidence suggests a significant role for complement activation in ANCA-associated vasculitis.

Purpose of the Study:

• To review the evidence for complement system activation in ANCA-associated vasculitis.
• To highlight the role of the alternative complement pathway in the pathogenesis.
• To synthesize findings from in vivo, in vitro, and clinical studies.

Main Methods:

• Review of existing scientific literature.
• Analysis of in vivo experimental data.
• Evaluation of in vitro laboratory findings.
• Examination of clinical study results.

Main Results:

• The complement system, especially the alternative pathway, is actively involved in ANCA-associated vasculitis.
• Evidence from multiple study types supports complement activation in the disease process.
• The "pauci-immune" classification may overlook crucial pathogenic mechanisms.

Conclusions:

• Complement system activation, particularly via the alternative pathway, is integral to ANCA-associated vasculitis pathogenesis.
• This review consolidates evidence demonstrating the complement system's role.
• Further research into complement inhibition may offer therapeutic strategies for ANCA-associated vasculitis.